FindTrial
Sign In

evaluation of OCTA following use of antiVEGF in retinal disease of eye in patients above 50 yrs

Evaluation of Optical coherence tomography angiography following use of anti vascular endothelial growth factor in exudative age related macular degeneration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050175
Enrollment
30
Registered
2023-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H353- Degeneration of macula and posterior pole

Interventions

Intervention1: Anti vascular endothelial growth factor: Anti vascular endothelial growth factor shall be injected intravitreally in patients with exudative age related macular degeneration and optical

Sponsors

MAULANA AZAD MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS OF EXUDATIVE AGE RELATED MACULAR DEGENERATION, WHO ARE ANTI VEGF NAIVE SUBJECTS HAVING BEST CORRECTED VISUAL ACUITY OF AT LEAST 6/60

Exclusion criteria

Exclusion criteria: SUBJECTS HAVING OTHER SIGNIFICANT OCULAR AND SYSTEMIC DISEASES RISK OF THROMBOEMBOLIC EVENTS AND/OR OCCURRENCE OF THESE WITHIN PAST 6 MONTHS

Design outcomes

Primary

MeasureTime frame
CHANGES IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY PARAMETERS 1.FOVEAL AVASCULAR ZONE 2.VESSEL DENSITY (SUPERFICIAL CAPILLARY PLEXUS , DEEP CAPILLARY PLEXUS AND FULL VESSEL DENSITY) 3.CHOROIDAL NEOVASCULAR MEMBRANE FOLLOWING ANTI VEGFTimepoint: 1 MONTH—

Secondary

MeasureTime frame
CHANGES IN BEST CORRECTED VISUAL ACUITY FOLLOWING ANTI VEGF CHANGES IN POSTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY PARAMETERS (CENTRAL FOVEAL THICKNESS AND SUB FOVEAL CHOROIDAL THICKNESS) FOLLOWING ANTI VEGFTimepoint: 1 MONTH—

Countries

India

Contacts

Public ContactDr Divya D

Maulana Azad Medical College

divyad993@gmail.com8970307441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026